Overview: HDL Cholesterol TestIntroduction: The HDL Cholesterol Test measures HDL cholesterol to assess heart disease risk, preventing heart attacks or chest pain. Following 2023 ACC/AHA guidelines, it uses an immunoassay for high sensitivity, aiding in cardiac screening. This test is critical for guiding risk assessment, lifestyle interventions, and improving outcomes in biochemistry for patients with suspected cardiovascular risk.
Other Names: HDL Cholesterol Assay, High-Density Lipoprotein Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: HDL cholesterol testing began in the 1970s with cardiovascular research. Immunoassays improved in the 1980s, enhancing accuracy for heart disease risk assessment.
Purpose: Assesses heart disease risk, guides preventive measures, and monitors HDL cholesterol levels in patients at risk for heart attacks or chest pain.
Test Parameters: 1. HDL Cholesterol
Pretest Condition: No fasting required, though fasting may be preferred for lipid panels. Collect serum or plasma at any time. Report symptoms like chest pain, and list medications.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document chest pain, heart disease history, or risk factors (e.g., smoking, hypertension). Include current medications, especially statins.
Consent: Written consent required, detailing the tests purpose, risk assessment implications, and potential need for lifestyle or medical interventions.
Procedural Considerations: Uses an immunoassay to measure HDL cholesterol levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Hemolysis, improper storage, or medications (e.g., statins, hormones) can affect results. Recent meals may alter lipid profiles.
Clinical Significance: Low HDL levels indicate higher heart disease risk, prompting lifestyle changes or treatment. Normal or high HDL levels suggest lower risk but require monitoring.
Specialist Consultation: Consult a cardiologist for result interpretation and cardiovascular risk management.
Additional Supporting Tests: LDL cholesterol, triglycerides, total cholesterol, or cardiac imaging to assess heart disease risk.
Test Limitations: HDL levels alone are insufficient for risk assessment. Comprehensive lipid profile and clinical correlation are needed.
References: ACC/AHA Lipid Guidelines, 2023; Circulation, Grundy SM, 2022.
